| | | | | | | | | | | | | | | | |
| | |
 | Issue Date FY: 2025 ( Subtotal = $0 ) |
| | 2025 | 2024 | THE POPULATION COUNCIL, INC. | 1 DAG HAMMARSKJOLD PLZ | NEW YORK | NY | 10017-2201 | NEW YORK | USA | P50HD106793 | Contraception development research center to advance a novel intravaginal ring as a non-hormonal multipurpose prevention technology | 001 | 4 | NIH | 3/11/2025 | $0 |
| | 2025 | 2024 | THE POPULATION COUNCIL, INC. | 1 DAG HAMMARSKJOLD PLZ | NEW YORK | NY | 10017-2201 | NEW YORK | USA | P50HD106793 | Contraception development research center to advance a novel intravaginal ring as a non-hormonal multipurpose prevention technology | 000 | 4 | NIH | 10/10/2024 | $0 |
|
| Issue Date FY: 2024 ( Subtotal = $3,893,509 ) |
| | 2024 | 2024 | THE POPULATION COUNCIL, INC. | 1 DAG HAMMARSKJOLD PLZ | NEW YORK | NY | 10017-2201 | NEW YORK | USA | R01AI150324 | Novel pre-coital, non-hormonal multipurpose prevention technology (MPT) | 001 | 5 | NIH | 5/23/2024 | $74,380 |
| | 2024 | 2024 | THE POPULATION COUNCIL, INC. | 1 DAG HAMMARSKJOLD PLZ | NEW YORK | NY | 10017-2201 | NEW YORK | USA | R01AI150324 | Novel pre-coital, non-hormonal multipurpose prevention technology (MPT) | 000 | 5 | NIH | 2/21/2024 | $669,416 |
| | 2024 | 2024 | THE POPULATION COUNCIL, INC. | 1 DAG HAMMARSKJOLD PLZ | NEW YORK | NY | 10017-2201 | NEW YORK | USA | P50HD106793 | Contraception development research center to advance a novel intravaginal ring as a non-hormonal multipurpose prevention technology | 001 | 4 | NIH | 8/13/2024 | $0 |
| | 2024 | 2024 | THE POPULATION COUNCIL, INC. | 1 DAG HAMMARSKJOLD PLZ | NEW YORK | NY | 10017-2201 | NEW YORK | USA | P50HD106793 | Contraception development research center to advance a novel intravaginal ring as a non-hormonal multipurpose prevention technology | 000 | 4 | NIH | 8/12/2024 | $2,344,029 |
| | 2024 | 2024 | THE POPULATION COUNCIL, INC. | 1 DAG HAMMARSKJOLD PLZ | NEW YORK | NY | 10017-2201 | NEW YORK | USA | R01AI150360 | An Etonogestrel/Ethinyl Estradiol/QGriffithsin (ETG/EE/QGRFT) IVR to Prevent Pregnancy and HIV | 002 | 5 | NIH | 4/16/2024 | $805,684 |
| | 2024 | 2023 | THE POPULATION COUNCIL, INC. | 1 DAG HAMMARSKJOLD PLZ | NEW YORK | NY | 10017-2201 | NEW YORK | USA | R34MH119982 | Combining PrEP with contraception: a pilot test of an intervention to increase adherence to PrEP in adolescent girls and young women in Zimbabwe | 000 | 3 | NIH | 9/16/2024 | $0 |
| | 2024 | 2023 | THE POPULATION COUNCIL, INC. | 1 DAG HAMMARSKJOLD PLZ | NEW YORK | NY | 10017-2201 | NEW YORK | USA | R01AI150360 | An Etonogestrel/Ethinyl Estradiol/QGriffithsin (ETG/EE/QGRFT) IVR to Prevent Pregnancy and HIV | 001 | 4 | NIH | 3/4/2024 | $0 |
| | 2024 | 2023 | THE POPULATION COUNCIL, INC. | 1 DAG HAMMARSKJOLD PLZ | NEW YORK | NY | 10017-2201 | NEW YORK | USA | NU2GGH002127 | Supporting Strategic Programming for Key and Priority Populations in Uganda through Enhanced Use of Data | 02 | 5 | CDC | 7/11/2024 | $0 |
| | 2024 | 2022 | THE POPULATION COUNCIL, INC. | 1 DAG HAMMARSKJOLD PLZ | NEW YORK | NY | 10017-2201 | NEW YORK | USA | R01AI150360 | An Etonogestrel/Ethinyl Estradiol/QGriffithsin (ETG/EE/QGRFT) IVR to Prevent Pregnancy and HIV | 000 | 3 | NIH | 2/23/2024 | $0 |
| | 2024 | 2022 | THE POPULATION COUNCIL, INC. | 1 DAG HAMMARSKJOLD PLZ | NEW YORK | NY | 10017-2201 | NEW YORK | USA | NU2GGH002127 | Supporting Strategic Programming for Key and Priority Populations in Uganda through Enhanced Use of Data | 02 | 5 | CDC | 7/11/2024 | $0 |
| | 2024 | 2021 | THE POPULATION COUNCIL, INC. | 1 DAG HAMMARSKJOLD PLZ | NEW YORK | NY | 10017-2201 | NEW YORK | USA | NU2GGH002127 | Supporting Strategic Programming for Key and Priority Populations in Uganda through Enhanced Use of Data | 02 | 5 | CDC | 7/11/2024 | $0 |
| | 2024 | 2021 | THE POPULATION COUNCIL, INC. | 1 DAG HAMMARSKJOLD PLZ | NEW YORK | NY | 10017-2201 | NEW YORK | USA | NU2GGH002127 | Supporting Strategic Programming for Key and Priority Populations in Uganda through Enhanced Use of Data | 02 | 5 | CDC | 7/11/2024 | $0 |
| | 2024 | 2020 | THE POPULATION COUNCIL, INC. | 1 DAG HAMMARSKJOLD PLZ | NEW YORK | NY | 10017-2201 | NEW YORK | USA | NU2GGH002127 | Supporting Strategic Programming for Key and Priority Populations in Uganda through Enhanced Use of Data | 02 | 5 | CDC | 7/11/2024 | $0 |
| | 2024 | 2020 | THE POPULATION COUNCIL, INC. | 1 DAG HAMMARSKJOLD PLZ | NEW YORK | NY | 10017-2201 | NEW YORK | USA | NU2GGH002127 | Supporting Strategic Programming for Key and Priority Populations in Uganda through Enhanced Use of Data | 02 | 5 | CDC | 7/11/2024 | $0 |
| | 2024 | 2019 | THE POPULATION COUNCIL, INC. | 1 DAG HAMMARSKJOLD PLZ | NEW YORK | NY | 10017-2201 | NEW YORK | USA | NU2GGH002127 | Supporting Strategic Programming for Key and Priority Populations in Uganda through Enhanced Use of Data | 02 | 5 | CDC | 7/11/2024 | $0 |
| | 2024 | 2018 | THE POPULATION COUNCIL, INC. | 1 DAG HAMMARSKJOLD PLZ | NEW YORK | NY | 10017-2201 | NEW YORK | USA | NU2GGH002127 | Supporting Strategic Programming for Key and Priority Populations in Uganda through Enhanced Use of Data | 02 | 5 | CDC | 7/11/2024 | $0 |
|
| Issue Date FY: 2023 ( Subtotal = $4,071,712 ) |
| | 2023 | 2023 | POPULATION COUNCIL, INC., THE | 1 DAG HAMMARSKJOLD PLZ FL 3 | NEW YORK | NY | 10017-2201 | NEW YORK | USA | R01AI150360 | An Etonogestrel/Ethinyl Estradiol/QGriffithsin (ETG/EE/QGRFT) IVR to Prevent Pregnancy and HIV | 000 | 4 | NIH | 3/1/2023 | $857,028 |
| | 2023 | 2023 | Population Council, Inc., The | 1 DAG HAMMARSKJOLD PLZ FL 3 | NEW YORK | NY | 10017-2201 | NEW YORK | USA | NU2GGH002127 | Supporting Strategic Programming for Key and Priority Populations in Uganda through Enhanced Use of Data | 01 | 5 | CDC | 2/28/2023 | $70,000 |
| | 2023 | 2023 | POPULATION COUNCIL, INC., THE | 1 DAG HAMMARSKJOLD PLZ FL 3 | NEW YORK | NY | 10017-2201 | NEW YORK | USA | P50HD106793 | Contraception development research center to advance a novel intravaginal ring as a non-hormonal multipurpose prevention technology | 000 | 3 | NIH | 8/28/2023 | $2,116,301 |
| | 2023 | 2023 | POPULATION COUNCIL, INC., THE | 1 DAG HAMMARSKJOLD PLZ FL 3 | NEW YORK | NY | 10017-2201 | NEW YORK | USA | R34MH119982 | Combining PrEP with contraception: a pilot test of an intervention to increase adherence to PrEP in adolescent girls and young women in Zimbabwe | 000 | 3 | NIH | 5/9/2023 | $119,473 |
| | 2023 | 2023 | POPULATION COUNCIL, INC., THE | 1 DAG HAMMARSKJOLD PLZ FL 3 | NEW YORK | NY | 10017-2201 | NEW YORK | USA | P50HD106793 | Contraception development research center to advance a novel intravaginal ring as a non-hormonal multipurpose prevention technology | 001 | 3 | NIH | 9/19/2023 | $0 |
| | 2023 | 2023 | POPULATION COUNCIL, INC., THE | 1 DAG HAMMARSKJOLD PLZ FL 3 | NEW YORK | NY | 10017-2201 | NEW YORK | USA | R01AI150324 | Novel pre-coital, non-hormonal multipurpose prevention technology (MPT) | 000 | 4 | NIH | 1/30/2023 | $908,910 |
| | 2023 | 2022 | Population Council, Inc., The | 1 DAG HAMMARSKJOLD PLZ FL 3 | NEW YORK | NY | 10017-2201 | NEW YORK | USA | NU2GGH002127 | Supporting Strategic Programming for Key and Priority Populations in Uganda through Enhanced Use of Data | 01 | 5 | CDC | 2/28/2023 | $0 |
| | 2023 | 2021 | POPULATION COUNCIL, INC., THE | 1 DAG HAMMARSKJOLD PLZ FL 3 | NEW YORK | NY | 10017-2201 | NEW YORK | USA | R34MH119982 | Combining PrEP with contraception: a pilot test of an intervention to increase adherence to PrEP in adolescent girls and young women in Zimbabwe | 001 | 3 | NIH | 7/21/2023 | $0 |
| | 2023 | 2021 | Population Council, Inc., The | 1 DAG HAMMARSKJOLD PLZ FL 3 | NEW YORK | NY | 10017-2201 | NEW YORK | USA | NU2GGH002127 | Supporting Strategic Programming for Key and Priority Populations in Uganda through Enhanced Use of Data | 01 | 5 | CDC | 2/28/2023 | $0 |
| | 2023 | 2021 | Population Council, Inc., The | 1 DAG HAMMARSKJOLD PLZ FL 3 | NEW YORK | NY | 10017-2201 | NEW YORK | USA | NU2GGH002127 | Supporting Strategic Programming for Key and Priority Populations in Uganda through Enhanced Use of Data | 01 | 5 | CDC | 2/28/2023 | $0 |
| | 2023 | 2020 | Population Council, Inc., The | 1 DAG HAMMARSKJOLD PLZ FL 3 | NEW YORK | NY | 10017-2201 | NEW YORK | USA | NU2GGH002127 | Supporting Strategic Programming for Key and Priority Populations in Uganda through Enhanced Use of Data | 01 | 5 | CDC | 2/28/2023 | $0 |
| | 2023 | 2020 | Population Council, Inc., The | 1 DAG HAMMARSKJOLD PLZ FL 3 | NEW YORK | NY | 10017-2201 | NEW YORK | USA | NU2GGH002127 | Supporting Strategic Programming for Key and Priority Populations in Uganda through Enhanced Use of Data | 01 | 5 | CDC | 2/28/2023 | $0 |
| | 2023 | 2019 | Population Council, Inc., The | 1 DAG HAMMARSKJOLD PLZ FL 3 | NEW YORK | NY | 10017-2201 | NEW YORK | USA | NU2GGH002127 | Supporting Strategic Programming for Key and Priority Populations in Uganda through Enhanced Use of Data | 01 | 5 | CDC | 2/28/2023 | $0 |
| | 2023 | 2018 | Population Council, Inc., The | 1 DAG HAMMARSKJOLD PLZ FL 3 | NEW YORK | NY | 10017-2201 | NEW YORK | USA | NU2GGH002127 | Supporting Strategic Programming for Key and Priority Populations in Uganda through Enhanced Use of Data | 01 | 5 | CDC | 2/28/2023 | $0 |
|
| Issue Date FY: 2022 ( Subtotal = $4,663,256 ) (Continued on the next page) |
| | 2022 | 2022 | POPULATION COUNCIL, INC., THE | 1 DAG HAMMARSKJOLD PLZ FL 3 | NEW YORK | NY | 10017-2201 | NEW YORK | USA | P50HD106793 | Contraception development research center to advance a novel intravaginal ring as a non-hormonal multipurpose prevention technology | 002 | 2 | NIH | 9/6/2022 | $2,334,952 |
| | 2022 | 2022 | Population Council, Inc., The | 1 DAG HAMMARSKJOLD PLZ FL 3 | NEW YORK | NY | 10017-2201 | NEW YORK | USA | NU2GGH002127 | Supporting Strategic Programming for Key and Priority Populations in Uganda through Enhanced Use of Data | 02 | 4 | CDC | 2/22/2022 | $0 |
| | 2022 | 2022 | POPULATION COUNCIL, INC., THE | 1 DAG HAMMARSKJOLD PLZ FL 3 | NEW YORK | NY | 10017-2201 | NEW YORK | USA | P50HD106793 | Contraception development research center to advance a novel intravaginal ring as a non-hormonal multipurpose prevention technology | 003 | 2 | NIH | 9/21/2022 | $0 |
| | 2022 | 2022 | Population Council, Inc., The | 1 DAG HAMMARSKJOLD PLZ FL 3 | NEW YORK | NY | 10017-2201 | NEW YORK | USA | NU2GGH002127 | Supporting Strategic Programming for Key and Priority Populations in Uganda through Enhanced Use of Data | 00 | 5 | CDC | 7/18/2022 | $200,000 |
| | 2022 | 2022 | Population Council, Inc., The | 1 Dag Hammarskjold Plz Fl 3 | New York | NY | 10017-2201 | NEW YORK | USA | NU2GGH002127 | Supporting Strategic Programming for Key and Priority Populations in Uganda through Enhanced Use of Data | 01 | 4 | CDC | 12/6/2021 | $261,053 |
| | 2022 | 2022 | POPULATION COUNCIL, INC., THE | 1 DAG HAMMARSKJOLD PLZ FL 3 | NEW YORK | NY | 10017-2201 | NEW YORK | USA | R01AI150360 | An Etonogestrel/Ethinyl Estradiol/QGriffithsin (ETG/EE/QGRFT) IVR to Prevent Pregnancy and HIV | 001 | 3 | NIH | 4/1/2022 | $987,021 |
| | 2022 | 2022 | POPULATION COUNCIL, INC., THE | 1 DAG HAMMARSKJOLD PLZ FL 3 | NEW YORK | NY | 10017-2201 | NEW YORK | USA | R01AI150324 | Novel pre-coital, non-hormonal multipurpose prevention technology (MPT) | 000 | 3 | NIH | 2/8/2022 | $880,230 |
| | 2022 | 2021 | POPULATION COUNCIL, INC., THE | 1 DAG HAMMARSKJOLD PLZ FL 3 | NEW YORK | NY | 10017-2201 | NEW YORK | USA | P50HD106793 | Contraception development research center to advance a novel intravaginal ring as a non-hormonal multipurpose prevention technology | 000 | 1 | NIH | 11/9/2021 | $0 |
| | 2022 | 2021 | Population Council, Inc., The | 1 DAG HAMMARSKJOLD PLZ FL 3 | NEW YORK | NY | 10017-2201 | NEW YORK | USA | NU2GGH002127 | Supporting Strategic Programming for Key and Priority Populations in Uganda through Enhanced Use of Data | 00 | 5 | CDC | 7/18/2022 | $0 |
| | 2022 | 2021 | Population Council, Inc., The | 1 DAG HAMMARSKJOLD PLZ FL 3 | NEW YORK | NY | 10017-2201 | NEW YORK | USA | NU2GGH002127 | Supporting Strategic Programming for Key and Priority Populations in Uganda through Enhanced Use of Data | 00 | 5 | CDC | 7/18/2022 | $0 |
| | 2022 | 2021 | Population Council, Inc., The | 1 Dag Hammarskjold Plz Fl 3 | New York | NY | 10017-2201 | NEW YORK | USA | NU2GGH002127 | Supporting Strategic Programming for Key and Priority Populations in Uganda through Enhanced Use of Data | 01 | 4 | CDC | 12/6/2021 | $0 |
| | 2022 | 2021 | Population Council, Inc., The | 1 Dag Hammarskjold Plz Fl 3 | New York | NY | 10017-2201 | NEW YORK | USA | NU2GGH002127 | Supporting Strategic Programming for Key and Priority Populations in Uganda through Enhanced Use of Data | 01 | 4 | CDC | 12/6/2021 | $0 |
| | 2022 | 2021 | Population Council, Inc., The | 1 DAG HAMMARSKJOLD PLZ FL 3 | NEW YORK | NY | 10017-2201 | NEW YORK | USA | NU2GGH002127 | Supporting Strategic Programming for Key and Priority Populations in Uganda through Enhanced Use of Data | 02 | 4 | CDC | 2/22/2022 | $0 |
| | 2022 | 2021 | Population Council, Inc., The | 1 DAG HAMMARSKJOLD PLZ FL 3 | NEW YORK | NY | 10017-2201 | NEW YORK | USA | NU2GGH002127 | Supporting Strategic Programming for Key and Priority Populations in Uganda through Enhanced Use of Data | 02 | 4 | CDC | 2/22/2022 | $0 |
|
